Altos Labs: A Startup In Silicon Valley Is Betting On Cellular Rejuvenation Programming To Enable Longevity swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
With $3 billion in capital and an executive team to be led by Hal Barron, MD, until now GlaxoSmithKline (GSK)’s President of R&D and Chief Scientific Officer, Altos Labs™ today emerged from stealth mode, launching as an anti-aging startup with the ambitious aim of reversing disease, injury, and disabilities through cellular rejuvenation programming.